In contrast, all mice treated with Pa-MAP in both concentrations survived at the end of experiment. The same pattern
was observed in mice treated with ampicillin ( Fig. 1B). Mice weights were further evaluated in the beginning and at the end of experiment. Infected and untreated mice lost 5.5% of their body weight after 72 h of experiment. In contrast, mice treated with Pa-MAP at 1 mg kg−1 gained 0.8% of their body weight, similar to Pa-MAP at 5 mg kg−1, which gained 0.5% of their body weight during the same period. Non-infected mice gained slightly more body weight (2.7%) compared to the Pa-MAP treatment groups. Infected mice treated with ampicillin at 2 mg kg−1 also had lost weight, equivalent to 5.6% of their initial body weight ( Fig. 1C and D). Some cytokines were evaluated selleckchem in attempt click here to identify an immunomodulatory effect of Pa-MAP in the mice immunologic system. This evaluation of immunomodulatory activity in vivo was investigated by quantification of IL-10, IL-12, TNF-α and NO in serum. Pa-MAP used as treatment
was evaluated at 1 mg kg−1, corresponding to a concentration of twice the minimum inhibitory concentration (MIC) of 512 μg mL−1 [34], and 5 mg kg−1, corresponding 10 times the MIC encountered in early study with Pa-MAP. Ampicillin at 2 mg kg−1 was used as a positive control. These concentrations of Pa-MAP were unable to modify IL-10 release when compared to the non-infected and untreated mice group. Similar data were observed for IL-12 and TNF-α production in all treatments groups
(Supplementary Fig. 1). Figure options Download full-size image Download as PowerPoint slide Antimicrobial resistance mechanisms developed by bacteria is a serious worldwide threat to public health, particularly for immunocompromised patients and those under immunosuppression therapy, e.g. patients oxyclozanide after organ transplant [29]. Moreover, infections caused by antibiotic-resistant microorganisms have contributed to increases in patient mortality, especially for those whose treatment with currently available drugs has become less efficient [14]. Due to these facts, peptides with antimicrobial activities have become extremely attractive for microorganisms control, mainly due their low toxicity effects into mammalian cells [24]. In our study, an alanine-rich peptide designed from a polar fish, P. americanus, with two repeat antifreeze motifs and clear in vitro deleterious activity against E. coli, with identical purification degree (see Fig. 1A) previously reported by Migliolo et al. [34] was evaluated in vivo. Some peptides were designed to develop a multifunctional product, able to eliminate microbes and increase the immune response, involving systematic variations in the structure of a base molecule, i.e. cationic charge, hydrophobicity and hydrophobic moment [21]. Moreover, some cationic peptides are known to be able to induce some immunomodulatory effect [37] and [62].